|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1902950380 |
| 003 |
DE-627 |
| 005 |
20230516031643.0 |
| 007 |
tu |
| 008 |
120910s2012 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw120908_1
|
| 035 |
|
|
|a (DE-627)OLC1902950380
|
| 035 |
|
|
|a (DE-599)GBVOLC1902950380
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a WA 15000
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.00
|2 bkl
|
| 100 |
1 |
|
|a Rampersaud, N.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions
|
| 264 |
|
1 |
|c 2012
|
| 300 |
|
|
|a 11
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Harkavyi, A.
|4 oth
|
| 700 |
1 |
|
|a Giordano, G.
|4 oth
|
| 700 |
1 |
|
|a Lever, R.
|4 oth
|
| 700 |
1 |
|
|a Whitton, J.
|4 oth
|
| 700 |
1 |
|
|a Whitton, P.S.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Neuropeptides
|d Amsterdam [u.a.] : Elsevier, 1980
|g 46(2012), 5 vom: Okt., Seite 183-194
|w (DE-627)129099430
|w (DE-600)9048-7
|w (DE-576)01443637X
|x 0143-4179
|7 nnns
|
| 773 |
1 |
8 |
|g volume:46
|g year:2012
|g number:5
|g month:10
|g pages:183-194
|g extent:11
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_55
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a WA 15000
|
| 936 |
b |
k |
|a 44.00
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 46
|j 2012
|e 5
|c 10
|h 183-194
|g 11
|
